File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1186/s12885-016-2201-9
- Scopus: eid_2-s2.0-84959153737
- WOS: WOS:000371666600002
Supplementary
- Citations:
- Appears in Collections:
Article: Efficacy and safety of afatinib in Chinese patients with EGFR-mutated metastatic non-small-cell lung cancer (NSCLC) previously responsive to first-generation tyrosine-kinase inhibitors (TKI) and chemotherapy: comparison with historical cohort using erlotinib
Title | Efficacy and safety of afatinib in Chinese patients with EGFR-mutated metastatic non-small-cell lung cancer (NSCLC) previously responsive to first-generation tyrosine-kinase inhibitors (TKI) and chemotherapy: comparison with historical cohort using erlotinib |
---|---|
Authors | |
Keywords | Afatinib Epidermal growth factor receptor mutation Erlotinib Non-small-cell lung cancer Tyrosine-kinase inhibitor |
Issue Date | 2016 |
Citation | BMC Cancer, 2016, v. 16, article no. 147 How to Cite? |
Persistent Identifier | http://hdl.handle.net/10722/227212 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, VHF | - |
dc.contributor.author | Leung, DENNIS KC | - |
dc.contributor.author | Choy, TIM SHING | - |
dc.contributor.author | Lam, KO | - |
dc.contributor.author | Lam, PUI MEI | - |
dc.contributor.author | Leung, TO WAI | - |
dc.contributor.author | Kwong, DLW | - |
dc.date.accessioned | 2016-07-18T09:09:06Z | - |
dc.date.available | 2016-07-18T09:09:06Z | - |
dc.date.issued | 2016 | - |
dc.identifier.citation | BMC Cancer, 2016, v. 16, article no. 147 | - |
dc.identifier.uri | http://hdl.handle.net/10722/227212 | - |
dc.language | eng | - |
dc.relation.ispartof | BMC Cancer | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | Afatinib | - |
dc.subject | Epidermal growth factor receptor mutation | - |
dc.subject | Erlotinib | - |
dc.subject | Non-small-cell lung cancer | - |
dc.subject | Tyrosine-kinase inhibitor | - |
dc.title | Efficacy and safety of afatinib in Chinese patients with EGFR-mutated metastatic non-small-cell lung cancer (NSCLC) previously responsive to first-generation tyrosine-kinase inhibitors (TKI) and chemotherapy: comparison with historical cohort using erlotinib | - |
dc.type | Article | - |
dc.identifier.email | Lee, VHF: vhflee@hku.hk | - |
dc.identifier.email | Lam, KO: lamkaon@hku.hk | - |
dc.identifier.email | Kwong, DLW: dlwkwong@hku.hk | - |
dc.identifier.authority | Lee, VHF=rp00264 | - |
dc.identifier.authority | Lam, KO=rp01501 | - |
dc.identifier.authority | Kwong, DLW=rp00414 | - |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.1186/s12885-016-2201-9 | - |
dc.identifier.scopus | eid_2-s2.0-84959153737 | - |
dc.identifier.hkuros | 258816 | - |
dc.identifier.volume | 16 | - |
dc.identifier.spage | article no. 147 | - |
dc.identifier.epage | article no. 147 | - |
dc.identifier.eissn | 1471-2407 | - |
dc.identifier.isi | WOS:000371666600002 | - |
dc.identifier.issnl | 1471-2407 | - |